Company intelligence
Omni-Biotic (AllergoSan USA)
Targeted probiotics for stress, immunity, detox, and development. Follow for microbiome science, news, and events.
About Omni-Biotic (AllergoSan USA)
Institut AllergoSan, a leader in gut microbiome and probiotic research and formulation, has served European pharmacies and practitioners for over 25 years. In partnership with AllergoSan USA, their evidence-based formulations are now available in the U.S. market. The Omni-Biotic® probiotic line is uniquely aligned with the Company's commitment to the highest quality, research, and evidence standards. This equates to every human source probiotic strain being identified and analyzed in vitro to determine its particular mechanistic strengths. Every probiotic formulation is further designed and tested for synergistic performance through preclinical and controlled human trials. Each product also undergoes gastric resistance and metabolic activity analysis as well as extended real-time stability testing, to ensure every serving delivers at full potency. Provided in powder form for rapid migration and robust metabolic activity, Omni-Biotic formulations are hypoallergenic and individually packaged for protection, portability, and convenience.
Verified activity
Signals from Omni-Biotic (AllergoSan USA)
3 published signals
Research & Knowledge
Omni-Biotic (AllergoSan USA) published a new paper investigating whether baseline gut microbiome and metabolomic profiles could predict response to a one-year structured weight-loss intervention in 50 adults with obesity.
Reported by Omni-Biotic (AllergoSan USA)
Research & Knowledge
Omni-Biotic (AllergoSan USA) published a research paper in the Journal of Advanced Research titled Research on the human microbiome has successfully evolved from gut-centric exploration into a comprehensive science recognizing that microbial communities are distributed throughout the body and collectively form a dynamic, interconnected functional network.
Reported by Omni-Biotic (AllergoSan USA)
Research & Knowledge
Omni-Biotic (AllergoSan USA) published a new study combining shotgun metagenomic sequencing of stool with proton magnetic resonance spectroscopy to examine gut microbial functional pathways alongside GABA and glutamate concentrations in specific brain regions in 61 healthy young women.
Reported by Omni-Biotic (AllergoSan USA)